Home | About IPJ | Editorial board | Ahead of print | Current Issue | Archives | Instructions | Contact us |   Login 
Industrial Psychiatry Journal
Search Articles   
Advanced search   

    Article Cited by others


Negative symptoms in schizophrenia

Mitra Sayantanava, Mahintamani Tathagata, Kavoor Anjana Rao, Nizamie S Haque

Year : 2016| Volume: 25| Issue : 2 | Page no: 135-144

   This article has been cited by
1 mRNA Expression of the CUB and Sushi Multiple Domains 1 (CSMD1) and Its Serum Protein Level as Predictors for Psychosis in the Familial High-Risk Children and Young Adults
Eman Masoud Abd El Gayed, Mohamed Soliman Rizk, Ahmed Nabil Ramadan, Noha Rabie Bayomy
ACS Omega. 2021; 6(37): 24128
[Pubmed]  [Google Scholar] [DOI]
2 Cariprazine as a therapeutic option for schizophrenia: a drug evaluation
Federico Mucci, Alessandra Della Vecchia, Stefano Baroni, Donatella Marazziti
Expert Opinion on Pharmacotherapy. 2021; 22(4): 415
[Pubmed]  [Google Scholar] [DOI]
3 Factors associated with overweight and obesity in Lebanese male patients with schizophrenia
Maha Kassem, Chadia Haddad, Christelle Daccache, Claire Hayek, Souheil Hallit, Francois Kazour
Perspectives in Psychiatric Care. 2021; 57(3): 1347
[Pubmed]  [Google Scholar] [DOI]
4 Associations between symptom severity and well-being among Thai patients with schizophrenia: a cross-sectional analytical study
Teerapat Teetharatkul, Arnont Vitayanont, Tippawan Liabsuetrakul, Warut Aunjitsakul
BMC Psychiatry. 2021; 21(1)
[Pubmed]  [Google Scholar] [DOI]
5 Negative symptoms in schizophrenia: clinical aspects and assessment
Andrey Olegovich Munin, Igor Vladlenovich Belokrylov
Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery). 2021; (6): 442
[Pubmed]  [Google Scholar] [DOI]
6 Neural noise and cortical inhibition in schizophrenia
Loïc Carment, Lucile Dupin, Laura Guedj, Maxime Térémetz, Macarena Cuenca, Marie-Odile Krebs, Isabelle Amado, Marc A. Maier, Påvel G. Lindberg
Brain Stimulation. 2020; 13(5): 1298
[Pubmed]  [Google Scholar] [DOI]
7 The muscarinic M1 receptor modulates associative learning and memory in psychotic disorders
Geor Bakker, Claudia Vingerhoets, Oswald J.N. Bloemen, Barbara J. Sahakian, Jan Booij, Matthan W.A. Caan, Thérèse A.M.J. van Amelsvoort
NeuroImage: Clinical. 2020; 27: 102278
[Pubmed]  [Google Scholar] [DOI]
8 Effects of different types of sensory signals on reaching performance in persons with chronic schizophrenia
Paul Sin-Bao Huang, Chiung-Ling Chen, Kwok-Tak Yeung, Ming-Yi Hsu, Sok-Wa Wan, Shu-Zon Lou, Robin Baurès
PLOS ONE. 2020; 15(6): e0234976
[Pubmed]  [Google Scholar] [DOI]
9 Dementia, delirium & neuropsychiatric conditions in Charaka indriya sthana
Kshama Gupta, Prasad Mamidi
Pharmacy & Pharmacology International Journal. 2020; 8(5): 297
[Pubmed]  [Google Scholar] [DOI]

Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority Study

Srihari Gopal, Jagadish Gogate, Katalin Pungor, Edward Kim, Arun Singh, Maju Mathews
Neuropsychiatric Disease and Treatment. 2020; Volume 16: 681
[Pubmed]  [Google Scholar] [DOI]
11 Role of Neurochemicals in Schizophrenia
Sher Singh, Deepa Khanna, Sanjeev Kalra
Current Psychopharmacology. 2020; 9(2): 144
[Pubmed]  [Google Scholar] [DOI]
12 Emerging 5-HT receptor antagonists for the treatment of Schizophrenia
Mackenzie T. Jones, Martin T. Strassnig, Philip D. Harvey
Expert Opinion on Emerging Drugs. 2020; 25(2): 189
[Pubmed]  [Google Scholar] [DOI]
13 ASHP Therapeutic Position Statement on the Use of Antipsychotic Medications in the Treatment of Adults with Schizophrenia and Schizoaffective Disorder
Jason M Noel, Cherry W Jackson
American Journal of Health-System Pharmacy. 2020; 77(24): 2114
[Pubmed]  [Google Scholar] [DOI]
14 Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial
Areoo Samaei, Kamyar Moradi, Sayna Bagheri, Amir Ashraf-Ganjouei, Rosa Alikhani, Seiedeh Bentolhoda Mousavi, Farzin Rezaei, Shahin Akhondzadeh
International Journal of Neuropsychopharmacology. 2020; 23(12): 775
[Pubmed]  [Google Scholar] [DOI]
15 Parasympathetic activity as a potential biomarker of negative symptoms in patients with schizophrenia
Wei-Chia Huang, Wei-Shih Liu, Tzu-ting Chen, Wen-Hao Chen, Wei-Lieh Huang
Asia-Pacific Psychiatry. 2020; 12(3)
[Pubmed]  [Google Scholar] [DOI]


Read this article